Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Pierre Fabre Laboratories receives European Commission Approval for BRAFTOVI®(encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation 2024-08-30 20:44
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China 2024-08-30 19:34
Fosun's Management: Globalization + Innovation + Asset-light Operations for Sustained and Stable Profits 2024-08-30 18:41
Breaking News | Sanyou Bio Launches Comprehensive Monkeypox Product Line 2024-08-30 18:00
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGFR exon 20 insertion mutations 2024-08-30 11:01
/DISREGARD RELEASE: Celltrion USA/ 2024-08-30 08:35
Remarkable Announcement on Significant Fluctuation of the UTime's Share Price 2024-08-30 00:33
Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to London 2024-08-29 21:51
CARsgen® Announces 2024 Interim Results 2024-08-29 20:50
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms 2024-08-29 20:42
UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics 2024-08-29 20:30
Medicilon Expands Global Presence with Official Opening of Second R&D Center in Massachusetts 2024-08-29 20:30
ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions 2024-08-29 20:00
So-Young Announces Receipt of Minimum Bid Price Notice from Nasdaq 2024-08-29 17:30
Discover the Top 6 Highlights of Medtec 2024 and Explore the Latest Industry Trends 2024-08-29 17:00
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results 2024-08-29 14:31
111, Inc. Announces Second Quarter 2024 Unaudited Financial Results 2024-08-29 14:00
Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan 2024-08-29 13:38
Smartee Hosts Breakthrough GS Mandibular Repositioning Therapy Conference in Singapore 2024-08-29 12:47
Smartee Showcases Iconic Orthodontic Solutions in Hong Kong, Expands Global Reach 2024-08-29 12:46
1 42 43 44 45 46 1596